UFP Technologies, Inc. (UFPT)
USD 187.03
(-3.41%)
USD 187.03
(-3.41%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 400.07 Million USD | 13.08% |
| 2022 | 353.79 Million USD | 71.48% |
| 2021 | 206.32 Million USD | 15.02% |
| 2020 | 179.37 Million USD | -9.58% |
| 2019 | 198.38 Million USD | 4.16% |
| 2018 | 190.45 Million USD | 28.82% |
| 2017 | 147.84 Million USD | 1.17% |
| 2016 | 146.13 Million USD | 5.24% |
| 2015 | 138.85 Million USD | -0.33% |
| 2014 | 139.3 Million USD | 0.06% |
| 2013 | 139.22 Million USD | 6.31% |
| 2012 | 130.96 Million USD | 2.92% |
| 2011 | 127.24 Million USD | 5.36% |
| 2010 | 120.76 Million USD | 21.7% |
| 2009 | 99.23 Million USD | -9.82% |
| 2008 | 110.03 Million USD | 17.56% |
| 2007 | 93.59 Million USD | -0.16% |
| 2006 | 93.74 Million USD | 11.66% |
| 2005 | 83.96 Million USD | 22.35% |
| 2004 | 68.62 Million USD | 12.68% |
| 2003 | 60.9 Million USD | -0.47% |
| 2002 | 61.18 Million USD | -0.62% |
| 2001 | 61.57 Million USD | -17.34% |
| 2000 | 74.49 Million USD | 26.69% |
| 1999 | 58.8 Million USD | 24.58% |
| 1998 | 47.2 Million USD | 3.74% |
| 1997 | 45.5 Million USD | 15.48% |
| 1996 | 39.4 Million USD | 15.54% |
| 1995 | 34.1 Million USD | 6.9% |
| 1994 | 31.9 Million USD | 4.59% |
| 1993 | 30.5 Million USD | 4.45% |
| 1992 | 29.2 Million USD | 3.91% |
| 1991 | 28.1 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 145.16 Million USD | 31.76% |
| 2024 Q2 | 110.17 Million USD | 4.92% |
| 2024 Q1 | 105 Million USD | 3.46% |
| 2023 Q2 | 100.03 Million USD | 2.34% |
| 2023 Q1 | 97.75 Million USD | 7.14% |
| 2023 FY | 400.07 Million USD | 13.08% |
| 2023 Q3 | 100.78 Million USD | 0.75% |
| 2023 Q4 | 101.49 Million USD | 0.71% |
| 2022 FY | 353.79 Million USD | 71.48% |
| 2022 Q4 | 91.23 Million USD | -5.91% |
| 2022 Q3 | 96.97 Million USD | 2.78% |
| 2022 Q2 | 94.34 Million USD | 32.43% |
| 2022 Q1 | 71.24 Million USD | 26.44% |
| 2021 Q1 | 48.59 Million USD | 7.63% |
| 2021 Q4 | 56.34 Million USD | 11.08% |
| 2021 FY | 206.32 Million USD | 15.02% |
| 2021 Q3 | 50.72 Million USD | 0.13% |
| 2021 Q2 | 50.65 Million USD | 4.23% |
| 2020 FY | 179.37 Million USD | -9.58% |
| 2020 Q1 | 48.27 Million USD | -3.95% |
| 2020 Q2 | 42.64 Million USD | -11.67% |
| 2020 Q3 | 43.29 Million USD | 1.54% |
| 2020 Q4 | 45.15 Million USD | 4.28% |
| 2019 Q1 | 47.32 Million USD | -6.65% |
| 2019 Q2 | 51.39 Million USD | 8.6% |
| 2019 Q3 | 49.39 Million USD | -3.9% |
| 2019 Q4 | 50.26 Million USD | 1.76% |
| 2019 FY | 198.38 Million USD | 4.16% |
| 2018 Q4 | 50.69 Million USD | 6.04% |
| 2018 FY | 190.45 Million USD | 28.82% |
| 2018 Q3 | 47.8 Million USD | -2.47% |
| 2018 Q1 | 42.93 Million USD | 15.35% |
| 2018 Q2 | 49.01 Million USD | 14.18% |
| 2017 Q4 | 37.21 Million USD | 4.3% |
| 2017 FY | 147.84 Million USD | 1.17% |
| 2017 Q2 | 37.88 Million USD | 2.25% |
| 2017 Q1 | 37.05 Million USD | 1.5% |
| 2017 Q3 | 35.68 Million USD | -5.81% |
| 2016 Q1 | 34.5 Million USD | 1.68% |
| 2016 FY | 146.13 Million USD | 5.24% |
| 2016 Q3 | 37.22 Million USD | -1.8% |
| 2016 Q4 | 36.5 Million USD | -1.92% |
| 2016 Q2 | 37.9 Million USD | 9.85% |
| 2015 Q4 | 33.93 Million USD | -1.47% |
| 2015 FY | 138.85 Million USD | -0.33% |
| 2015 Q2 | 36.49 Million USD | 7.42% |
| 2015 Q1 | 33.97 Million USD | -3.66% |
| 2015 Q3 | 34.44 Million USD | -5.64% |
| 2014 Q4 | 35.26 Million USD | -0.39% |
| 2014 Q3 | 35.4 Million USD | 4.06% |
| 2014 Q2 | 34.02 Million USD | -1.69% |
| 2014 Q1 | 34.6 Million USD | -1.1% |
| 2014 FY | 139.3 Million USD | 0.06% |
| 2013 Q2 | 35.83 Million USD | 6.34% |
| 2013 FY | 139.22 Million USD | 6.31% |
| 2013 Q1 | 33.69 Million USD | 0.98% |
| 2013 Q3 | 34.7 Million USD | -3.16% |
| 2013 Q4 | 34.99 Million USD | 0.84% |
| 2012 Q1 | 31.95 Million USD | 1.51% |
| 2012 Q3 | 31.96 Million USD | -5.07% |
| 2012 Q4 | 33.37 Million USD | 4.39% |
| 2012 Q2 | 33.67 Million USD | 5.39% |
| 2012 FY | 130.96 Million USD | 2.92% |
| 2011 FY | 127.24 Million USD | 5.36% |
| 2011 Q4 | 31.47 Million USD | 2.33% |
| 2011 Q3 | 30.76 Million USD | -8.18% |
| 2011 Q2 | 33.5 Million USD | 6.34% |
| 2011 Q1 | 31.5 Million USD | -0.43% |
| 2010 FY | 120.76 Million USD | 21.7% |
| 2010 Q1 | 28.7 Million USD | -1.19% |
| 2010 Q2 | 29.95 Million USD | 4.38% |
| 2010 Q3 | 30.46 Million USD | 1.7% |
| 2010 Q4 | 31.64 Million USD | 3.85% |
| 2009 FY | 99.23 Million USD | -9.82% |
| 2009 Q2 | 20.95 Million USD | -3.0% |
| 2009 Q1 | 21.6 Million USD | -17.1% |
| 2009 Q4 | 29.04 Million USD | 5.16% |
| 2009 Q3 | 27.62 Million USD | 31.78% |
| 2008 FY | 110.03 Million USD | 17.56% |
| 2008 Q2 | 28.45 Million USD | 1.6% |
| 2008 Q1 | 28 Million USD | 9.99% |
| 2008 Q4 | 26.06 Million USD | -5.22% |
| 2008 Q3 | 27.5 Million USD | -3.36% |
| 2007 Q4 | 25.46 Million USD | 11.02% |
| 2007 FY | 93.59 Million USD | -0.16% |
| 2007 Q3 | 22.93 Million USD | -1.05% |
| 2007 Q2 | 23.18 Million USD | 5.3% |
| 2007 Q1 | 22.01 Million USD | -5.68% |
| 2006 FY | 93.74 Million USD | 11.66% |
| 2006 Q4 | 23.33 Million USD | 7.36% |
| 2006 Q3 | 21.73 Million USD | -11.4% |
| 2006 Q2 | 24.53 Million USD | 1.63% |
| 2006 Q1 | 24.14 Million USD | 4.04% |
| 2005 Q3 | 21.64 Million USD | 3.5% |
| 2005 Q4 | 23.2 Million USD | 7.18% |
| 2005 Q2 | 20.91 Million USD | 14.98% |
| 2005 Q1 | 18.19 Million USD | -0.07% |
| 2005 FY | 83.96 Million USD | 22.35% |
| 2004 Q4 | 18.2 Million USD | 3.1% |
| 2004 FY | 68.62 Million USD | 12.68% |
| 2004 Q2 | 16.82 Million USD | 5.61% |
| 2004 Q1 | 15.93 Million USD | 4.5% |
| 2004 Q3 | 17.65 Million USD | 4.93% |
| 2003 Q1 | 14.24 Million USD | 3.77% |
| 2003 FY | 60.9 Million USD | -0.47% |
| 2003 Q4 | 15.24 Million USD | -5.03% |
| 2003 Q3 | 16.05 Million USD | 4.58% |
| 2003 Q2 | 15.35 Million USD | 7.78% |
| 2002 Q1 | 15.53 Million USD | 2.23% |
| 2002 Q4 | 13.72 Million USD | -10.18% |
| 2002 FY | 61.18 Million USD | -0.62% |
| 2002 Q3 | 15.28 Million USD | -8.2% |
| 2002 Q2 | 16.64 Million USD | 7.2% |
| 2001 Q3 | 13.93 Million USD | -9.98% |
| 2001 FY | 61.57 Million USD | -17.34% |
| 2001 Q1 | 16.96 Million USD | -5.18% |
| 2001 Q2 | 15.48 Million USD | -8.76% |
| 2001 Q4 | 15.19 Million USD | 9.02% |
| 2000 Q4 | 17.89 Million USD | -5.31% |
| 2000 Q3 | 18.89 Million USD | -2.67% |
| 2000 Q2 | 19.41 Million USD | 6.19% |
| 2000 Q1 | 18.28 Million USD | 14.27% |
| 2000 FY | 74.49 Million USD | 26.69% |
| 1999 Q3 | 14.4 Million USD | -3.36% |
| 1999 Q2 | 14.9 Million USD | 10.37% |
| 1999 Q1 | 13.5 Million USD | 8.0% |
| 1999 FY | 58.8 Million USD | 24.58% |
| 1999 Q4 | 16 Million USD | 11.11% |
| 1998 Q1 | 10.7 Million USD | -10.08% |
| 1998 Q2 | 11.3 Million USD | 5.61% |
| 1998 Q3 | 12.7 Million USD | 12.39% |
| 1998 Q4 | 12.5 Million USD | -1.57% |
| 1998 FY | 47.2 Million USD | 3.74% |
| 1997 FY | 45.5 Million USD | 15.48% |
| 1997 Q2 | 11.2 Million USD | 1.82% |
| 1997 Q3 | 11.4 Million USD | 1.79% |
| 1997 Q1 | 11 Million USD | 4.76% |
| 1997 Q4 | 11.9 Million USD | 4.39% |
| 1996 Q2 | 10.1 Million USD | 16.09% |
| 1996 FY | 39.4 Million USD | 15.54% |
| 1996 Q3 | 10.1 Million USD | 0.0% |
| 1996 Q4 | 10.5 Million USD | 3.96% |
| 1996 Q1 | 8.7 Million USD | -1.14% |
| 1995 Q3 | 8.4 Million USD | 1.2% |
| 1995 Q4 | 8.8 Million USD | 4.76% |
| 1995 Q1 | 8.6 Million USD | 7.5% |
| 1995 Q2 | 8.3 Million USD | -3.49% |
| 1995 FY | 34.1 Million USD | 6.9% |
| 1994 Q3 | 8 Million USD | -4.76% |
| 1994 Q1 | 7.5 Million USD | -5.06% |
| 1994 Q2 | 8.4 Million USD | 12.0% |
| 1994 FY | 31.9 Million USD | 4.59% |
| 1994 Q4 | 8 Million USD | 0.0% |
| 1993 Q1 | 7.5 Million USD | 2.74% |
| 1993 Q2 | 7.5 Million USD | 0.0% |
| 1993 Q3 | 7.6 Million USD | 1.33% |
| 1993 Q4 | 7.9 Million USD | 3.95% |
| 1993 FY | 30.5 Million USD | 4.45% |
| 1992 Q3 | 7.3 Million USD | 0.0% |
| 1992 FY | 29.2 Million USD | 3.91% |
| 1992 Q4 | 7.3 Million USD | 0.0% |
| 1992 Q1 | 7.3 Million USD | 2.82% |
| 1992 Q2 | 7.3 Million USD | 0.0% |
| 1991 Q4 | 7.1 Million USD | 1.43% |
| 1991 FY | 28.1 Million USD | 0.0% |
| 1991 Q1 | 7 Million USD | 0.0% |
| 1991 Q2 | 7 Million USD | 0.0% |
| 1991 Q3 | 7 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 12.05 Million USD | -3217.622% |
| BrainsWay Ltd. | 31.78 Million USD | -1158.682% |
| Cerus Corporation | 156.36 Million USD | -155.854% |
| Envoy Medical, Inc. | 316 Thousand USD | -126505.063% |
| electroCore, Inc. | 16.03 Million USD | -2395.77% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -62022.981% |
| IceCure Medical Ltd | 3.22 Million USD | -12289.966% |
| Inogen, Inc. | 315.66 Million USD | -26.741% |
| OrthoPediatrics Corp. | 148.73 Million USD | -168.989% |
| Lucid Diagnostics Inc. | 2.42 Million USD | -16377.43% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -109509.067% |
| MaxCyte, Inc. | 41.28 Million USD | -868.979% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | -20390.862% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -361145.35% |
| Orthofix Medical Inc. | 746.64 Million USD | 46.417% |
| PAVmed Inc | 2.45 Million USD | -16216.15% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | -1676.598% |
| RxSight, Inc. | 89.07 Million USD | -349.131% |
| Sight Sciences, Inc. | 81.05 Million USD | -393.575% |
| SI-BONE, Inc. | 138.88 Million USD | -188.058% |
| TELA Bio, Inc. | 58.45 Million USD | -584.434% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | -113.807% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | -2798.862% |
| Acutus Medical, Inc. | 7.16 Million USD | -5484.478% |
| Talis Biomedical Corporation | 412 Thousand USD | -97004.854% |
| Spectral AI, Inc. | 18.05 Million USD | -2115.729% |
| Nano-X Imaging Ltd. | 9.9 Million USD | -3939.091% |
| CVRx, Inc. | 39.29 Million USD | -918.124% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -41199.631% |
| Bioventus Inc. | 512.34 Million USD | 21.914% |
| Venus Concept Inc. | 76.35 Million USD | -423.97% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | -2061.266% |
| LivaNova PLC | 1.15 Billion USD | 65.318% |
| 908 Devices Inc. | 50.22 Million USD | -696.496% |
| Alphatec Holdings, Inc. | 482.26 Million USD | 17.043% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -519177.296% |
| NeuroPace, Inc. | 65.42 Million USD | -511.535% |
| LENSAR, Inc. | 42.16 Million USD | -848.847% |
| Apyx Medical Corporation | 52.34 Million USD | -664.24% |
| Cutera, Inc. | 212.36 Million USD | -88.385% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | -1099.329% |
| BioSig Technologies, Inc. | 18 Thousand USD | -2222522.222% |
| Anika Therapeutics, Inc. | 166.66 Million USD | -140.05% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | -1570.098% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 74.048% |
| Axonics, Inc. | 366.37 Million USD | -9.196% |
| Outset Medical, Inc. | 130.37 Million USD | -206.86% |
| IRIDEX Corporation | 51.86 Million USD | -671.312% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | -193.758% |
| IRadimed Corporation | 65.56 Million USD | -510.217% |
| Tivic Health Systems, Inc. | 1.17 Million USD | -33919.728% |
| INVO Bioscience, Inc. | 3.02 Million USD | -13144.895% |
| Telesis Bio, Inc. | 27.5 Million USD | -1354.331% |
| Viemed Healthcare, Inc. | 183 Million USD | -118.609% |
| Varex Imaging Corporation | 811 Million USD | 50.669% |
| Quipt Home Medical Corp. | 221.74 Million USD | -80.422% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | -482.558% |
| Dynatronics Corporation | 32.53 Million USD | -1129.706% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | -4510.187% |
| Semler Scientific, Inc. | 68.18 Million USD | -486.753% |
| InMode Ltd. | 492.04 Million USD | 18.692% |
| Bruker Corporation | 2.96 Billion USD | 86.505% |
| Cytosorbents Corporation | 36.34 Million USD | -1000.63% |
| DexCom, Inc. | 3.62 Billion USD | 88.955% |
| Align Technology, Inc. | 3.86 Billion USD | 89.642% |
| Viveve Medical, Inc. | 6.42 Million USD | -6125.833% |
| ZimVie Inc. | 457.43 Million USD | 12.54% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | -107.275% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -361145.35% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | 46.494% |
| Profound Medical Corp. | 7.33 Million USD | -5357.248% |
| Insulet Corporation | 1.69 Billion USD | 76.426% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | -217.321% |
| iCAD, Inc. | 17.31 Million USD | -2210.151% |
| Nuwellis, Inc. | 8.86 Million USD | -4413.448% |
| Biotricity, Inc. | 12.06 Million USD | -3216.427% |
| iRhythm Technologies, Inc. | 492.68 Million USD | 18.797% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | -6347.575% |
| PAVmed Inc. | 2.45 Million USD | -16216.15% |
| BIOLASE, Inc. | 49.16 Million USD | -713.75% |
| Beyond Air, Inc. | 1.15 Million USD | -34418.723% |
| FONAR Corporation | 102.88 Million USD | -288.857% |
| AxoGen, Inc. | 159.01 Million USD | -151.599% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | -45.787% |
| Inari Medical, Inc. | 493.63 Million USD | 18.953% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -2150824.731% |
| Tenon Medical, Inc. | 2.92 Million USD | -13563.661% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | -5773.015% |
| AdaptHealth Corp. | 3.2 Billion USD | 87.498% |
| Sintx Technologies, Inc. | 2.62 Million USD | -15129.235% |
| NanoVibronix, Inc. | 2.28 Million USD | -17423.96% |
| Quanterix Corporation | 122.36 Million USD | -226.942% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | -1539.303% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | -99.516% |
| TransMedics Group, Inc. | 241.62 Million USD | -65.577% |
| ReWalk Robotics Ltd. | 13.85 Million USD | -2787.772% |
| NeuroMetrix, Inc. | 5.9 Million USD | -6679.244% |
| Hyperfine, Inc. | 11.03 Million USD | -3526.468% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | -142.246% |
| Biomerica, Inc. | 5.41 Million USD | -7288.218% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | -691.266% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | -125.858% |